Brandon Holtrup
Private Equity Investor chez Oberland Capital Management LLC
Profil
Dr. Holtrup is a Vice President at Oberland Capital.
Prior to joining Oberland, Dr. Holtrup was an Associate Director in Global Analytics & Insight (Early Oncology) at AstraZeneca, where he focused on evaluating the commercial potential of early-stage assets.
Previously, Dr. Holtrup was a Consultant at L.E.K.
Consulting, where he provided strategic management advising to pharmaceutical and biotech companies.
Dr. Holtrup completed a PhD at Yale University, focusing on the molecular mechanisms governing metabolism and obesity.
Dr. Holtrup also holds a B.S.
from DePaul University in Biology.
Postes actifs de Brandon Holtrup
| Sociétés | Poste | Début |
|---|---|---|
Oberland Capital Management LLC
 Oberland Capital Management LLC Investment ManagersFinance Oberland Capital Management LLC (Oberland Capital) is a private equity firm founded in 2013 by Jean-Pierre Naegeli and Andrew Rubinstein. The firm is headquartered in New York. | Private Equity Investor | 01/02/2023 |
Formation de Brandon Holtrup
| Yale University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Oberland Capital Management LLC
Oberland Capital Management LLC Investment ManagersFinance Oberland Capital Management LLC (Oberland Capital) is a private equity firm founded in 2013 by Jean-Pierre Naegeli and Andrew Rubinstein. The firm is headquartered in New York. | Finance |